Pharmaceutical Glass Packaging Market
Pharmaceutical Glass Packaging Market by Type (Ampoules, Vials, Bottles, Syringes), Material (Type I, Type II, Type III), Drug Type, Manufacturing Process, Application (Injectables, Vaccines, Biologics), End user, and Region - Global Forecast To 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The pharmaceutical glass packaging market is projected to reach USD 6.36 billion by 2030 from USD 3.10 billion in 2025, at a CAGR of 15.5% from 2025 to 2030. Pharmaceutical glass packaging refers to specialized glass containers and delivery systems designed to preserve the efficacy and stability of pharmaceutical products. These materials are engineered to be chemically inert and compatible with sensitive drug formulations, making them essential for various medical applications, such as vials, ampoules, syringes, and bottles, used in injectable drug delivery, biologics storage, and sterile pharmaceutical preparations.
KEY TAKEAWAYS
-
By RegionAsia Pacific is anticipated to exhibit the highest CAGR of 17.0% during the forecast period, driven by increased healthcare investments and demand for sustainable packaging solutions in the region.
-
By MaterialThe type I neutral or borosilicate glass segment is expanding significantly due to its superior chemical and thermal properties that ensure drug integrity and sterility.
-
By TypeAmpoules and vials are critical segments for injectable drug packaging due to their ability to maintain drug integrity and provide contamination-free storage for biologics and high-potency pharmaceuticals.
-
By ApplicationBy application, the injectables segment accounted for the largest market share of 45% in 2025, driven by the extensive use of vials, ampoules, and prefilled syringes for biologics, vaccines, and sterile drugs.
-
Competitive Landscape - Star PlayersSchott AG, Gerresheimer AG, and Nipro were identified as leading players in the pharmaceutical glass packaging market, given their innovative capabilities, expansive product portfolios, and global market presence with strategic focus on sustainability and technological advancements.
-
Competitive Landscape - StartupsThe market analysis did not identify specific startups or SMEs with distinguished positions in specialized niche areas, as the pharmaceutical glass packaging sector is predominantly served by established manufacturers with extensive regulatory compliance capabilities.
The pharmaceutical glass packaging market is expanding rapidly, driven by the increasing use of glass in drug delivery systems, especially in vials and ampoules for injectables. The growing biopharmaceutical sector, rising demand for sterile packaging, and advancements in glass treatment processes that enhance drug protection and patient safety are further accelerating demand for high-quality pharmaceutical glass packaging solutions across global markets.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The pharmaceutical glass packaging market is currently experiencing a phase of innovation and rapid adoption. Healthcare systems and pharmaceutical manufacturers across North America, Europe, Asia Pacific, South America, and the Middle East & Africa are witnessing advancements in glass manufacturing technologies and regulatory frameworks. This progress aligns with emerging trends in biologics development, personalized medicine, and advanced drug delivery systems. In the pharmaceutical industry, the use of Type I borosilicate glass, advanced coating technologies, and specialized glass formulations is increasing among drug manufacturers and biopharmaceutical companies. These materials facilitate the safe storage and delivery of sensitive biologics, vaccines, and injectable medications, which promote better drug stability, reduce contamination risks, and align with stringent regulatory requirements for pharmaceutical packaging. Governments and regulatory bodies are encouraging innovation in glass treatment processes, the development of eco-friendly glass packaging solutions, and public-private research programs focused on enhancing glass performance characteristics. These initiatives help ensure compliance with evolving safety standards and promote the adoption of advanced glass packaging platforms tailored to the needs of modern pharmaceutical applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising demand for secure and contamination-free packaging solutions
-
Growth in biopharmaceuticals and biologics requiring superior chemical stability
Level
-
High cost of production and fragility of glass leading to handling challenges
Level
-
Advancements in coating technologies that minimize glass breakage and enhance product shelf life
Level
-
Balancing innovation with regulatory compliance and maintaining cost-effectiveness amidst rising raw material prices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising demand for secure and contamination-free packaging solutions
The rising demand for secure and contamination-free packaging solutions is a primary driver of the pharmaceutical glass packaging market. Glass packaging offers inert properties that make it ideal for preserving the efficacy and stability of high-potency drugs such as biologics. Pharmaceutical companies are increasingly adopting glass containers to ensure drug integrity, prevent chemical interactions, and maintain sterility throughout the product lifecycle, supporting the growth of injectable medications and sensitive pharmaceutical formulations.
Restraint: High cost of production and fragility of glass leading to handling challenges
The high cost of production associated with pharmaceutical-grade glass manufacturing and the inherent fragility of glass containers present significant restraints to market growth. The specialized processes required to produce Type I borosilicate glass and other pharmaceutical-grade materials involve substantial capital investment and energy consumption. Additionally, the breakage risk during transportation, handling, and storage creates logistical challenges and increases overall packaging costs for pharmaceutical manufacturers.
Opportunity: Advancements in coating technologies that minimize glass breakage and enhance product shelf life
Advancements in coating technologies represent a significant growth opportunity in the pharmaceutical glass packaging market. Innovative surface treatments and protective coatings are being developed to minimize glass breakage, reduce particle shedding, and enhance the mechanical strength of glass containers. These technological improvements not only address handling challenges but also extend product shelf life and improve patient safety, making glass packaging more competitive and attractive for pharmaceutical applications.
Challenge: Balancing innovation with regulatory compliance and maintaining cost-effectiveness amidst rising raw material prices
Balancing innovation with regulatory compliance while maintaining cost-effectiveness remains a key challenge for pharmaceutical glass packaging manufacturers. The industry must navigate stringent regulations on pharmaceutical packaging materials that promote the use of glass for its safety and compliance characteristics, while simultaneously managing rising raw material costs and production expenses. Manufacturers must invest in advanced manufacturing processes, quality control systems, and regulatory validation to ensure their products meet evolving safety standards without compromising economic viability.
PHARMACEUTICAL GLASS PACKAGING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides Type I borosilicate glass vials and ampoules for injectable biologics and vaccines, serving pharmaceutical manufacturers across multiple therapeutic areas with specialized glass formulations designed for high-potency drug storage. | Ensures superior chemical resistance, thermal stability, and drug compatibility, supporting the safe storage and delivery of sensitive biologics while meeting stringent regulatory requirements for pharmaceutical packaging. |
 |
Supplies pharmaceutical glass containers, including vials, syringes, and cartridges with advanced coating technologies to biopharmaceutical companies and vaccine manufacturers, offering customized glass packaging solutions for injectable drug delivery systems. | Provides enhanced mechanical strength, reduced breakage risk, and improved product shelf life, enabling reliable drug delivery and supporting the growing demand for prefilled syringes and ready-to-use pharmaceutical containers. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The pharmaceutical glass packaging market is a collaborative ecosystem where glass manufacturers, pharmaceutical companies, biopharmaceutical firms, regulatory agencies, and healthcare providers work together to develop and implement safe packaging solutions for the pharmaceutical sector. Companies in the industry supply a variety of glass packaging products, including vials, ampoules, syringes, bottles, and cartridges made from Type I borosilicate glass and other specialized formulations. Contract manufacturing organizations, quality testing laboratories, and research institutions support the development, validation, and scale-up processes for pharmaceutical glass packaging solutions. Ultimately, pharmaceutical manufacturers and healthcare institutions utilize these glass packaging products, benefiting from their inert properties, regulatory compliance, and ability to maintain drug stability and efficacy throughout the product lifecycle.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Pharmaceutical Glass Packaging Market, by Type
Ampoules and vials dominated the market in 2025, serving as the backbone of injectable drug packaging used daily in hospitals, clinics, and pharmaceutical manufacturing facilities. This dominance is due to their ability to maintain drug integrity and sterility, proven performance in protecting sensitive biologics, and widespread acceptance for packaging high-potency pharmaceuticals and vaccines.
Pharmaceutical Glass Packaging Market, by Application
Injectable drug packaging represented the largest segment of the pharmaceutical glass packaging market. The increasing prevalence of chronic diseases requiring injectable therapies and the rapid growth of the biopharmaceutical sector have propelled this segment to the forefront globally. Factors such as the expanding biologics market, growing demand for vaccines, increasing adoption of prefilled syringes, and the need for sterile packaging solutions are driving the demand for glass vials, ampoules, and syringe systems across therapeutic areas.
REGION
Asia Pacific to be fastest-growing region in pharmaceutical glass packaging market during forecast period
Asia Pacific is projected to be the fastest-growing regional market for pharmaceutical glass packaging, at a CAGR of 17.0%, driven by increased healthcare investments, expanding pharmaceutical manufacturing capabilities, and strong government support for healthcare infrastructure development. The demand for biologics, vaccines, and injectable medications is increasing across the region, along with the production of pharmaceutical products and packaging materials in countries such as China, India, Japan, and South Korea. Additionally, significant investment in biopharmaceutical research and development, combined with growing healthcare expenditure and demand for sustainable packaging solutions, is facilitating the swift adoption of advanced pharmaceutical glass packaging technologies—from development to commercial application.
PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY EVALUATION MATRIX
Schott AG, recognized as a leading player in the pharmaceutical glass packaging market, offers a diverse portfolio that includes Type I borosilicate glass vials, ampoules, syringes, and cartridges for pharmaceutical and biopharmaceutical applications. The company boasts a strong global manufacturing presence and collaborates with pharmaceutical companies, vaccine manufacturers, and biologics developers across North America, Europe, and Asia Pacific. Another significant player in the market is Gerresheimer AG, identified as a major competitor with extensive capabilities. The company is strengthening its position by introducing advanced coating technologies, eco-friendly glass packaging solutions, and specialized glass formulations designed for use in injectable drug delivery, biologics storage, and vaccine packaging applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Schott AG (Germany)
- Gerresheimer AG (Germany)
- Nipro Corporation (Japan)
- Stevanato Group (Italy)
- SGD Pharma (France)
- Ardagh Group (Luxembourg)
- Bormioli Pharma (Italy)
- Owens-Illinois (US)
- Piramal Glass (India)
- Corning Incorporated (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 3.10 Billion |
| Market Forecast in 2030 (Value) | USD 6.36 Billion |
| Growth Rate | CAGR of 15.5% from 2025 to 2030 |
| Years Considered | 2022-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type: Ampoules, Vials, Bottles, Syringes l Material: Type I Neutral or Borosilicate Glass, Type II Treated Soda-Lime Glass, Type III Soda-Lime Glass l Drug Type: Generic, Branded, Biological l Manufacturing Process: Tubular, Molded l Application: Injectables, Vaccines, High-potency Drugs, Biologics, Generic Pharmaceuticals, OTC Medications l End user: Pharmaceutical Companies, Contract Manufacturing Organizations, Biotechnology Companies, Research Laboratories |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East & Africa |
WHAT IS IN IT FOR YOU: PHARMACEUTICAL GLASS PACKAGING MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Understanding demand patterns for pharmaceutical glass packaging across global healthcare systems | Assessed pharmaceutical glass packaging usage trends across key regions including North America, Europe, Asia Pacific, South America, and Middle East & Africa, highlighting differences in adoption of vials, ampoules, syringes, and bottles across injectable drugs, biologics, vaccines, and pharmaceutical formulation applications | Helps clients align product portfolios with region-specific demand drivers, regulatory requirements, biopharmaceutical growth trends, and healthcare infrastructure development |
| Identifying manufacturing capabilities and sourcing opportunities | Mapped regional pharmaceutical glass packaging manufacturers, contract packaging organizations, and specialty glass producers across major markets, with insights into borosilicate glass production, coating technology capabilities, quality control systems, and regulatory compliance infrastructure | Supports supply chain optimization strategies, reduces procurement risk, ensures regulatory compliance, improves production efficiency, and enhances speed-to-market for pharmaceutical products |
RECENT DEVELOPMENTS
- January 2024 : Schott AG launched a new line of eco-friendly glass ampoules, aligning with sustainability goals and environmental responsibility initiatives in pharmaceutical packaging, demonstrating enhanced recyclability and reduced environmental impact while maintaining the superior chemical resistance and drug compatibility required for pharmaceutical applications.
- September 2023 : Gerresheimer AG achieved FDA clearance for its latest glass vial coating technology, which enhances mechanical strength and reduces particle shedding, supporting improved patient safety and drug stability for injectable pharmaceutical products and biologics.
- March 2023 : Gerresheimer AG merged with a local glass tooling firm to expand its manufacturing capacity and enhance production capabilities for pharmaceutical glass containers, strengthening its position in key growth markets and improving supply chain resilience.
- August 2022 : Schott AG partnered with major pharmaceutical companies to enhance glass vial production capabilities and develop specialized packaging solutions for biologics and high-potency drug formulations, supporting the growing demand for advanced pharmaceutical glass packaging in the biopharmaceutical sector.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The study involved four major activities to estimate the current size of the Pharmaceutical Glass Packaging Market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the Pharmaceutical Glass Packaging Market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.
Secondary Research
The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the Pharmaceutical Glass Packaging Market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.
Primary Research
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the Pharmaceutical Glass Packaging Market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate and validate the size of the global Pharmaceutical Glass Packaging Market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:
Pharmaceutical Glass Packaging Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).
Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.
Stakeholders
- Pharmaceutical packaging manufacturers
- Raw material suppliers
- Converters & processors
- Distributors and traders
- Industry associations and regulatory bodies
- End users
Report Objectives
- To define, describe, and forecast the size of the Pharmaceutical Glass Packaging Market, based on type, packaging type, drug delivery, raw material, and region in terms of value and volume
- To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
- To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
- To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
- To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the Pharmaceutical Glass Packaging Market
- To provide the impact of AI/Gen AI on the market
Available Customizations
With the given market data, MarketsandMarkets offers customizations according to client-specific needs.
The following customization options are available for the Pharmaceutical Glass Packaging Market report:
Product Analysis
- A product matrix that gives a detailed comparison of the product portfolio of each company
Geographic Analysis as per Feasibility
- A further breakdown of the Pharmaceutical Glass Packaging Market for additional countries
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Glass Packaging Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Still Researching the
Pharmaceutical Glass Packaging Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Growth opportunities and latent adjacency in Pharmaceutical Glass Packaging Market